[Extremely low birth weight (less than 1000 gram) and early postnatal weight gain in preterm infants]

T Decsi1, A Reizer, K Adamovich

  • 1Pécsi Tudományegyetem, Gyermekgyógyászati Klinika.

Orvosi Hetilap
|November 23, 2000
PubMed

Insights

Postnatal nutrition is crucial for extremely low birthweight preterm infants. Early weeks show significantly lower weight gain compared to in utero growth, highlighting the need for improved infant nutrition strategies.

Area of Science:

  • Neonatalogy and Perinatal Medicine
  • Pediatric Nutrition
  • Growth and Development

Context:

  • Improving survival rates of extremely low birthweight (ELBW) infants (<1000 g) presents challenges in postnatal nutrition and growth.
  • ELBW infants require specialized nutritional support to achieve optimal growth trajectories.
  • Understanding growth patterns in the early weeks is critical for long-term outcomes.

Purpose:

  • To investigate the nutritional status and weight gain patterns of ELBW preterm infants during the first 12 weeks of life.
  • To compare the postnatal weight gain of ELBW infants with in utero fetal growth rates.
  • To identify critical periods for nutritional intervention in ELBW infants.

Summary:

  • Sixteen ELBW preterm infants (birthweight: 890 ± 22 g, gestational age: 28.0 ± 0.2 weeks) were studied over 12 weeks, fed maternal milk, fortified pooled human milk, or preterm formula.
  • Infants approximated birthweight by week 3. Cumulative weight gain by week 8 was significantly lower (76% vs. 136%) than theoretical controls.
  • Weight gain velocity was lower in early weeks but surpassed controls by week 8, indicating a critical early window for nutritional support.

Impact:

  • Early postnatal weeks are vital for optimizing nutrition in ELBW infants.
  • Findings suggest that current nutritional strategies may not fully compensate for intrauterine growth deficits in the initial weeks.
  • Further research into enhanced nutritional interventions during the first weeks of life is warranted to improve ELBW infant outcomes.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...